Touch Medical Media
Touch Medical Media - educating physicians on a fully global scale since 2005!
We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.
Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinion to support best practice for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates
Home of:
- touchONCOLOGY
- touchENDOCRINOLOGY
- touchOPHTHALMOLOGY
- touchNEUROLOGY
- touchCARDIOLOGY
- touchINFECTIOUSDISEASES
- touchIMMUNOLOGY
- touchRESPIRATORY
- touchHAEMATOLOGY
- touchDERMATOLOGY
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
FCS unmasked: Closing Gaps in diagnosis, treatment and patient support
Effective lifespan care in sickle cell disease: From recognizing the burden to novel therapeutics
Applying patient and disease characteristics to guide R/M NPC treatment
Bridging the diagnostic and therapeutic gaps in Fabry disease management
Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies
Phacoemulsification in cataract surgery: Evolving options to optimize refractive outcomes
Stargardt disease: Improving awareness, diagnosis, and patient support
A case-based discussion on PAH: Early detection, risk stratification and treatment decision-making
Mastering DKA management: From pathophysiology to prevention and ketone monitoring strategies
Continuous glucose monitoring for cardiovascular risk reduction: Next frontier in preventive care
HER2 as a targetable biomarker in gastrointestinal oncology
Navigating the evolving role of immunotherapy in advanced endometrial carcinoma
Focus on treatment advances for ATTRv: A heterogeneous, debilitating & ultimately fatal disease
Advancing care for patients with infantile hemangioma: Timing is key
Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025
Accelerating myasthenia gravis diagnosis and treatment: Practical strategies & therapeutic advances
Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist
Multidisciplinary management of TNBC: Integrating immunotherapies for early and metastatic disease
Personalised care for people living with HIV: Supporting open dialogue & informed treatment choices
Applying immunotherapy in clinical practice for patients with early stage NSCLC
RET-positive NSCLC: Translating insights into targeted approaches
Advances in dry eye disease: From diagnosis to new treatment targets
Recent advances in the care of patients with geographic atrophy: Exploring new & emerging therapies
Reducing burden of disease in gMG: Exploring the role of FcRn inhibitors
The potential of BTKi therapies in progressive forms of MS
Empowering T2D management: The evolution of basal insulin therapy
Navigating the clinical impact of TROP2-targeting in NSCLC
The evolving standard of care for advanced/recurrent endometrial cancer
Tailoring treatment in myelofibrosis: Addressing anaemia and thrombocytopenia
touchMDT ADCs in metastatic breast cancer: Managing toxicities and optimizing quality of life